Early stage deals and IPO activity upThe high-tech entrepreneur has at last got some hope again, especially with reports telling us that early stage VC deals in Europe are up, and that the number of venture-backed European IPOs is 2004 was the highest since 2000. According to the European Venture Capital Report from VentureOne, a unit of Dow Jones and Ernst & Young, the total number of VC deals fell by 20% but early stage rounds represented one-third of all deals in Europe in 2004 —compared to 28% in 2003. The percentage of early stage deals steadily increased throughout 2004, with 35% of the deals in the fourth quarter alone targeted at seed and first rounds. On the IPO front, 34 venture-backed European companies completed initial public offerings (IPOs) in 2004, raising a total of €712 million – a significant improvement over the nine IPOs that raised €129 million in 2003. The number of IT firms that went to IPO in Europe exceeded the number in the US, where the health care sector was more buoyant. The 2004 European IPO figure was the highest since 2000, when there were 178 IPOs that raised €11.8 billion. Early stage VC deals For the first time since 2000, annual investment in European venture-capital-backed companies held steady, with €3.5 billion invested in 2004 – nearly the same amount that was invested in 2003. However, deal flow for the year decreased to 1,026 rounds – a 20% drop in activity from 2003. In contrast, the amount invested into US venture-backed companies in 2004 surpassed 2003 levels. The fact that European investment stabilised after four years of decline was viewed in a positive light. Semiconductor VC investment drops “Some of the factors which contributed to recent growth in US venture capital investment are now being observed in Europe,” said Gil Forer, Ernst & Young’s global venture capital advisory group leader. “In 2004, Europe saw significantly higher M & A valuations and the most VC-backed IPOs in three years, creating a clearer path to quality exits for investors which was likely an important dynamic in the stabilisation in European funding levels last year. Since venture-capital investment in Europe generally lags the US trend by approximately two quarters, there is reason to be cautiously optimistic that European investment will take up the US trend and shift from stabilisation to improvement in 2005.” “The growing size of European venture-capital deals is a positive factor,” said Stephen Harmston, VentureOne’s director of international research. “It also indicates that the companies able to secure a financing round are receiving investments that may sustain them as they seek potential partnerships and/or exit opportunities.” By industry, investment into European healthcare companies increased 19% to €1.5 billion in 2004, even though there were 40 fewer healthcare deals in 2004. In fact, of the 10 largest deals that occurred in the fourth quarter, all were for healthcare companies. The largest deal was the €40 million first-round investment in Novexel (Romainville, France), a developer of treatments for fungal and bacterial infections. Investment into energy-related companies also increased, with four more deals for the year and €33.5 million more capital invested in this segment. “Thanks to more progressive energy policies in Europe, this segment is beginning to garner significant interest among investors,” Harmston said. IPO trend on the up However, it took the current crop of IPO companies nearly a year longer than last year to reach IPO status – about 4.3 years, compared to 3.4 years in 2003. “This shows that European investors are still focused on portfolio companies that were initially financed during the bubble years of 1999 and 2000,” Harmston added. “Some 47% of the companies that reached IPO this year were initially financed during that period.” The 2004 IPO companies performed better in the public market than in preceding years. The median pre-money valuation of European IPO companies was €39.5 million, up from €26.9 million last year. Amongst the European IPO companies, five were in communications and networking and four each in the semiconductor and software segments. The largest IPOs of the fourth quarter in Europe were flat-panel display technology developer Cambridge Display Technology (NASDAQ: OLED), which was valued at €195.5 million at its IPO, and a surgical device maker Inion (LSE: IIN.L), which was valued at €130.5 million. By geography, the United Kingdom was responsible for the majority of the year’s IPOs: 23, which raised a total of €409 million. Norway was the second most active in terms of the number of IPOs, completing five for a total amount raised at €46 million. M & A activity still healthy The median amount paid in M&As for these venture-backed companies was €26 million, more than double the €10.6 million median paid last year and almost reaching the highest median amount paid in 2000, at €30 million. VC investment in UK and Ireland reaches juncture The largest investment round recorded in 2004 was the R2 round of £28 million made in Microsulis (Microwave technology) lead by 3i and Media2k. The largest R1 was £12 million in CRLO Displays (silicon based displays), lead by Doughty Hanson and Amadeus - no doubt, buoyed by the recent successful IPO of Cambridge Display Technology. Regionally, activities in Scotland increased to 12 deals, while Ireland activity was down to 9, way down from 18 deals in 2003. Most active investors during 2004 were 3i and Scottish Equity. Other notable activity was recorded from Cross Atlantic, Doughty Hanson, Benchmark and Accel. |
||
© Chilli Publishing Ltd 2004 |
15FEB2005 |
|


